Wyden Statement on Parliamentarian Drug Pricing Rulings

Wyden Statement on Parliamentarian Drug Pricing Rulings

Senate Finance Committee Chair Ron Wyden, D-Ore., today issued a statement following the Senate Parliamentarian's rulings on the compliance of Senate Democrats' reconciliation language related to prescription drug pricing reform:

"Senate Democrats wrote our reconciliation language to comply with Senate rules, and the parliamentarian has largely agreed, especially on groundbreaking Medicare negotiation and cost protections for seniors," Wyden said. "I am disappointed that the calculation for the Medicare inflation rebate that included commercial units sold was ruled out of compliance, but the legislation nevertheless puts a substantial check on Big Pharma's ability to price gouge. I look forward to moving ahead on this critical legislation to lower drug prices for seniors and taxpayers."

###